Mallinckrodt to Provide Fiscal 2014 Guidance
Company will hold conference call on Wednesday October 16
DUBLIN--(BUSINESS WIRE)--Oct. 2, 2013--
(NYSE: MNK), a leading global specialty pharmaceuticals company, will
provide fiscal 2014 financial guidance on October, 16, 2013. The company
will hold a conference call for investors beginning at 8:30am/U.S.
Eastern Daylight Time. The call can be accessed in three ways.
At the Mallinckrodt website: http://mallinckrodt.com/investor_relations.aspx
By telephone: For both “listen-only” participants and those who wish
to take part in the question-and-answer portion of the call, the
telephone dial-in number in the U.S. is 800-688- 0836. For
participants outside the U.S., the dial-in number is 617-614-4072. The
access code for all callers is 12188938.
Through an audio replay: A replay of the call will be available
beginning at 12:30pm/ U.S. Eastern Daylight Time on October 16, 2013,
and ending at 12:59am/ U.S. Eastern Daylight Time on October 23, 2013.
The dial-in number for U.S. participants is 888-286-8010. For
participants outside the U.S., the replay dial-in number is 617-
801-6888. The replay access code for all callers is 51623490.
Mallinckrodt is a leading global specialty pharmaceuticals business that
develops, manufactures, markets and distributes specialty pharmaceutical
products and medical imaging agents. The company’s Specialty
Pharmaceuticals segment includes branded and generic drugs, and the
Global Medical Imaging segment includes contrast media and nuclear
imaging agents. Mallinckrodt has approximately 5,500 employees
worldwide. The company’s 2012 revenue totaled $2.1 billion. To learn
more about Mallinckrodt, visit www.mallinckrodt.com.
John Moten, 314-654-6650
Vice President, Investor
Manager, Media Relations
Senior Vice President, Communications